Changes in the expression of the peroxisome proliferator-activated receptor γ gene in the colonic polyps and colonic mucosa of acromegalic patients

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3938-3942

  Bogazzi, Fausto ^a   Ultimieri, Federica ^a   Raggi, Francesco ^a   Russo, Dania ^a   Viacava, Paolo ^a   Cecchetti, Denise ^a   Costa, Aurelio ^a   Brogioni, Sandra ^a   Cosci, Chiara ^a   Gasperi, Maurizio ^a   Bartalena, Luigi ^b   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLON POLYP; COLON TUMOR; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREVALENCE; PRIORITY JOURNAL; REMISSION; TUMOR SUPPRESSOR GENE;

ACROMEGALY; ADULT; COLON; COLONIC POLYPS; COLONOSCOPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS;

EID: 0042383390     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030273     Document Type: Article

References (28)

1. Desvergne B, Wahli W 1999 Peroxisome proliferator activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688
2. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H 1997 Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator activated receptors and liver X receptor α in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327
3. Lowell BB 1999 PPARγ: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99:239-242
4. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Hlden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM 1998 Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 4:1046-1052
5. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, Coombel JF, Najib J, Fruchart JC, Datz C, Vidal H, Desreumaux P, Auwerx J 1999 Peroxisome proliferator-activated receptor γ is induced during differentiation of colon epithelium cells. J Endocrinol 62:331-340
6. Huin C, Corriveau L, Keller JM, Collet P, Kremarik-Bouillaud P, Domenjoud L, Becuwe P, Schohn H, Menard D, Dauça M 2000 Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem 48:1-9
7. Gupta RA, DuBois RN2002 Controversy. PPARγ as a target for treatment of colorectal cancer. Am J Physiol 283:G266-G268
8. Sporn MB, Suh N, Mangelsdorf DJ 2001 Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs). Trends Mol Med 7:395-400
9. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360
10. Demetri GD, Fletcher CDM, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM, Singer S1999 Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96:3951-3956
11. Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP 1998 Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344-3352
12. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP 1998 Ligands for peroxisome proliferator activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and BNX mice. Proc Natl Acad Sci USA 95:8806-8811
13. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, Najib J, Laville M, Fruchart JC, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J 1997 The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272:18779-18789
14. Min/+ mice. Nat Med 4:1053-1057
15. Tanaka T, Kohno H, Yoshitani S, Takashima S, Okumura A, Murakami A, Hosokawa M 2001 Ligands for peroxisome proliferator activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 61:2424-2428
16. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, Baird SM, Thomazy VA, Evans RM 1998 Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 4:1058-1061
17. Girnun GD, Smith WM, Drori S, Sarraf P, Mueller E, Eng C, Nambiar P, Rosenberg DW, Bronson RT, Edelmann W, Kucherlapati R, Gonzalez FJ, Spiegelman BM 2002 APC-dependent suppression of colon carcinigenesis by PPARγ. Proc Natl Acad Sci USA 99:13771-13776
18. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C1999 Loss-of-function mutations in PPARγ associated with human colon cancer. Mol Cell 3:799-804
19. Ikezoe T, Miller CW, Kawano S, Heaney A, Williamson EA, Hisatake J, Green E, Hofmann W, Taguchi H, Koeffler HP 2001 Mutational analysis of the peroxisome proliferator activated receptor γ gene in human malignancies. Cancer Res 61:5307-5310
20. Bogazzi F, Ultimieri F, Raggi F, Costa A, Gasperi M, Cecconi E, Mosca F, Bartalena L, Martino E 2002 Peroxisome proliferator activated receptor γ expression is reduced in the colonic mucosa of acromegalic patients. J Clin Endocrinol Metab 87:2403-2406
21. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M 1997 Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 47:17-22
22. Colao A, Balzano A, Ferone D, Panza N, Grande G, Marzullo P, Bove A, Iodice G, Merola B, Lombardi G 1997 Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) 47:23-28
23. Jenkins PJ, Frajese V, Jones A-M, Camacho-Hubner C, Lowe DG, Fairclough PD, Chew SL, Grossman AB, Monson JP, Besser GM 2000 Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218-3221
24. Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N 1992 Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer. 65:341-346
25. Gupta RA, Brockman JA, Sarraf P, Willson M, DuBois RN2001 Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells. J Biol Chem 276:29681-29687
26. Brockman JA, Gupta RA, DuBois RN1998 Activation of PPARγ leads to inhibition of anchorage independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055
27. Smith WM, Zhou XP, Kurose K, Gao X, Latif F, Kroll T, Cannistra SA, Clinton SK, Maher ER, Prior TW, Eng C2001 Opposite association of two PPARG variants with cancers: overexpression of H469H in endometrial carcinoma cases and underexpression of P12A in renal carcinoma cases. Hum Genet 109:146-151
28. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, Kantoff PW2000 Effects of ligand activation of peroxisome proliferator activated receptor γ in human prostate cancer. Proc Natl Acad Sci USA 97:10990-10995